Karen Bergman Email Address

Vice President, Communications and Investor Relations

FibroGen creates first-in-class medicines to treat chronic and life-threatening conditions such as anemia, idiopathic pulmonary fibrosis, and pancreatic cancer.

An accomplished corporate and product communications, investor relations, corporate website development, business development and industry relations professional with more than two decades of U.S. and global experience in biotechnology, pharmaceuticals, medical device and technology industries. Karen provides senior-level strategic planning and high-quality execution of branding and competitive analysis, investor relations, corporate, product and employee communications, issues management, executive coaching and presentation training, and industry and advocacy relations to innovative life science and pharmaceutical companies at all stages of development. Karen brings rich insight and expertise that builds value, and achieves a differentiated and enduring brand and reputation.